210 related articles for article (PubMed ID: 11756179)
1. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.
Benekli M; Xia Z; Donohue KA; Ford LA; Pixley LA; Baer MR; Baumann H; Wetzler M
Blood; 2002 Jan; 99(1):252-7. PubMed ID: 11756179
[TBL] [Abstract][Full Text] [Related]
2. Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia.
Xia Z; Sait SN; Baer MR; Barcos M; Donohue KA; Lawrence D; Ford LA; Block AM; Baumann H; Wetzler M
Leuk Res; 2001 Jun; 25(6):473-82. PubMed ID: 11337019
[TBL] [Abstract][Full Text] [Related]
3. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.
Xia Z; Baer MR; Block AW; Baumann H; Wetzler M
Cancer Res; 1998 Jul; 58(14):3173-80. PubMed ID: 9679986
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
5. STAT isoforms: mediators of STAT specificity or leukemogenesis?
Ilaria RL
Leuk Res; 2001 Jun; 25(6):483-4. PubMed ID: 11337020
[No Abstract] [Full Text] [Related]
6. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
7. Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells.
Ning ZQ; Li J; Arceci RJ
Blood; 2001 Jun; 97(11):3559-67. PubMed ID: 11369651
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
[TBL] [Abstract][Full Text] [Related]
9. A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts.
Xia Z; Salzler RR; Kunz DP; Baer MR; Kazim L; Baumann H; Wetzler M
Cancer Res; 2001 Feb; 61(4):1747-53. PubMed ID: 11245492
[TBL] [Abstract][Full Text] [Related]
10. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.
Schuringa JJ; Wierenga AT; Kruijer W; Vellenga E
Blood; 2000 Jun; 95(12):3765-70. PubMed ID: 10845908
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription proteins in leukemias.
Benekli M; Baer MR; Baumann H; Wetzler M
Blood; 2003 Apr; 101(8):2940-54. PubMed ID: 12480704
[TBL] [Abstract][Full Text] [Related]
12. Stat3 and G-CSF-induced myeloid differentiation.
Chakraborty A; Tweardy DJ
Leuk Lymphoma; 1998 Aug; 30(5-6):433-42. PubMed ID: 9711905
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
[TBL] [Abstract][Full Text] [Related]
14. Differential binding activity of the transcription factor LIL-STAT in immature and differentiated normal and leukemic myeloid cells.
Tuyt LM; Bregman K; Lummen C; Dokter WH; Vellenga E
Blood; 1998 Aug; 92(4):1364-73. PubMed ID: 9694725
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
16. WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).
Faderl S; Ferrajoli A; Harris D; Van Q; Priebe W; Estrov Z
Anticancer Res; 2005; 25(3B):1841-50. PubMed ID: 16158916
[TBL] [Abstract][Full Text] [Related]
17. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
[TBL] [Abstract][Full Text] [Related]
18. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
[TBL] [Abstract][Full Text] [Related]
19. STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells.
Zhang J; Shen B; Li Y; Sun Y
Leuk Res; 2001 Jun; 25(6):463-72. PubMed ID: 11337018
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]